| Gene symbol | TNFRSF8 | Synonyms | CD30, D1S166E, Ki-1 | Type of gene | protein-coding | |
| Chromosome | 1 | Map location | 1p36.22 | dbXrefs | Entrez:943 MIM:153243 HGNC:HGNC:11923 Ensembl:ENSG00000120949 AllianceGenome:HGNC:11923 | |
| Description | TNF receptor superfamily member 8 | |||||
| GTO ID | GTC2137 |
| Trial ID | NCT04008394 |
| Disease | Hodgkin's Lymphoma | NK/T-Cell Lymphoma | Anaplastic Large Cell Lymphoma | Peripheral T-Cell Lymphoma | Adult T-Cell Leukemia/Lymphoma | Angioimmunoblastic T-Cell Lymphoma |
| Altered gene | CD30 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD30 CAR-T cells |
| Generation | 3rd |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | Anti-CD30 CAR-T Therapy in Patients With Refractory/Relapsed Lymphocyte Malignancies |
| Year | 2019 |
| Country | China |
| Company sponsor | Wuhan Union Hospital, China |
| Other ID(s) | WHUH-CART-CD30-01 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||